Amivas Drug Patent Portfolio
Amivas owns 1 orange book drug protected by 1 US patent Given below is the list of Amivas's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12121506 | Artesunate powders, pharmaceutical compositions and methods of manufacture | 16 Feb, 2044 | Active |
Latest Legal Activities on Amivas's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Amivas.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Email Notification | 22 Oct, 2024 | US12121506 |
| Mail Patent eGrant Notification | 22 Oct, 2024 | US12121506 |
| Patent Issue Date Used in PTA Calculation | 22 Oct, 2024 | US12121506 |
| Recordation of Patent eGrant | 22 Oct, 2024 | US12121506 |
| Recordation of Patent Grant Mailed | 22 Oct, 2024 | US12121506 |
| Patent eGrant Notification | 22 Oct, 2024 | US12121506 |
| Email Notification | 02 Oct, 2024 | US12121506 |
| Issue Notification Mailed | 02 Oct, 2024 | US12121506 |
| Dispatch to FDC | 19 Sep, 2024 | US12121506 |
| Application Is Considered Ready for Issue | 19 Sep, 2024 | US12121506 |
| Issue Fee Payment Verified | 16 Sep, 2024 | US12121506 |
| Issue Fee Payment Received | 16 Sep, 2024 | US12121506 |
| Mail Notice of Allowance | 05 Sep, 2024 | US12121506 |
| Notice of Allowance Data Verification Completed | 02 Sep, 2024 | US12121506 |
| Interview Summary - Examiner Initiated - Telephonic | 29 Aug, 2024 | US12121506 |
Amivas's Family Patents
Amivas Drug List
Given below is the complete list of Amivas's drugs and the patents protecting them.
1. Artesunate
Artesunate is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12121506 | Artesunate powders, pharmaceutical compositions and methods of manufacture |
16 Feb, 2044
(17 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Artesunate's drug page